- In October 2024, Teleflex Incorporated launched the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada. These devices are designed to enhance peripherally inserted central catheter (PICC) insertion procedures, providing real-time catheter tip location information and improved navigation, reducing complications
- In May 2024, Graminex L.L.C. announced the completion of a clinical trial investigating the efficacy of its flower pollen extract products, Graminex RCT Fem UI and Graminex PollenBerry, in treating urinary incontinence in women. The study demonstrated significant improvements in urinary incontinence severity and related symptoms
- In May 2024, Graminex L.L.C. announced the publication of a peer-reviewed clinical study in the journal Current Urology. The study focused on the use of Graminex Flower Pollen Extract for women's urinary incontinence and urinary health, providing scientific validation for the product's efficacy
- In October 2023, Ambu A/S obtained European regulatory clearance (CE mark) for its Ambu aScope 5 Cysto HD, a single-use cystoscope integrated with the Ambu aView 2 Advance endoscopy system. This product offers urologists advanced imaging capabilities, contributing to improved diagnostic accuracy and patient care
- In August 2023, Fresenius Medical Care announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its NxStage VersiHD with GuideMe Software, a chronic home hemodialysis system. The new system aims to enhance patient and nurse experience through a self-guided interface, improving ease of use and confidence
